BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 26171319)

  • 1. FoxO proteins in the nervous system.
    Maiese K
    Anal Cell Pathol (Amst); 2015; 2015():569392. PubMed ID: 26171319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
    Maiese K
    Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(4):404-13. PubMed ID: 26256004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders.
    Oli V; Gupta R; Kumar P
    J Chem Neuroanat; 2021 Oct; 116():102012. PubMed ID: 34400291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO in Neural Cells and Diseases of the Nervous System.
    Santo EE; Paik J
    Curr Top Dev Biol; 2018; 127():105-118. PubMed ID: 29433734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
    Maiese K
    Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
    Maiese K
    J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Forkhead Transcription Factors of the O Class (FoxO) in Development and Progression of Alzheimer's Disease.
    Goswami S; Kareem O; Goyal RK; Mumtaz SM; Tonk RK; Gupta R; Pottoo FH
    CNS Neurol Disord Drug Targets; 2020; 19(9):709-721. PubMed ID: 33001019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A "FOXO" in sight: targeting Foxo proteins from conception to cancer.
    Maiese K; Chong ZZ; Shang YC; Hou J
    Med Res Rev; 2009 May; 29(3):395-418. PubMed ID: 18985696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "O" class: crafting clinical care with FoxO transcription factors.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.
    Maiese K; Chong ZZ; Wang S; Shang YC
    Int J Mol Sci; 2012 Oct; 13(11):13830-66. PubMed ID: 23203037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic FoxO transcription factors.
    Huang H; Tindall DJ
    J Cell Sci; 2007 Aug; 120(Pt 15):2479-87. PubMed ID: 17646672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the tumor suppressor function of FOXO as an alternative therapeutic approach in cancer.
    Singh A; Plati J; Khosravi-Far R
    Curr Drug Targets; 2011 Aug; 12(9):1311-21. PubMed ID: 21443464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.
    Maiese K
    Neural Regen Res; 2021 Mar; 16(3):448-455. PubMed ID: 32985464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
    Maiese K
    Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of FOXO Factors in Mammalian Cells.
    Brown AK; Webb AE
    Curr Top Dev Biol; 2018; 127():165-192. PubMed ID: 29433737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
    Maiese K
    Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fork in the path: Developing therapeutic inroads with FoxO proteins.
    Maiese K; Hou J; Chong ZZ; Shang YC
    Oxid Med Cell Longev; 2009; 2(3):119-29. PubMed ID: 20592766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.